ASCO

6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Mon, 06/1/15 - 09:43 am
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
TheStreet.com
Mon, 06/1/15 - 09:41 am
Clovis Oncology
ASCO
rucaparib
AstraZeneca
Lynparza
rociletinib
AZD9291
Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients
Yahoo
Sun, 05/31/15 - 11:57 am
Halozyme
PEGPH20
ASCO
metastatic pancreatic cancer
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Yahoo
Sun, 05/31/15 - 11:30 am
Infinity Pharmaceuticals
ASCO
duvelisib
chronic lymphocytic leukemia
CLL
Your ASCO15 guide: A mixed bag for Bristol-Myers, big wins for Merck, J&J
BioPharma Dive
Sun, 05/31/15 - 11:21 am
ASCO
Bristol-Myers Squibb
JNJ
Merck
Keytruda
Opdivo
daratumumab
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
Fierce Biotech
Sun, 05/31/15 - 11:18 am
ASCO
Celldex
glioblastoma multiforme
brain cancer
Rintega
Genentech's PD-L1 breakthrough star 'atezo' positioned to vault ahead on cancer
Fierce Biotech
Sun, 05/31/15 - 11:15 am
Genentech
anti-PD-L1
atezolizumab
ASCO
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
TheStreet.com
Sat, 05/30/15 - 05:44 pm
ASCO
CTI BioPharma
myelofibrosis
pacritinib
Jakafi
Incyte
Clovis Oncology’s Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Highly Compelling Clinical Activity
Yahoo
Sat, 05/30/15 - 05:41 pm
Clovis Oncology
ASCO
rucaparib
ovarian cancer
Roche's Gazyva doubles remission time for non-Hodgkin lymphoma patients
Fierce Pharma
Sat, 05/30/15 - 05:36 pm
Roche
Gazyva
non-Hodgkin's lymphoma
ASCO
Pfizer's breast cancer-fighter Ibrance posts stellar second-line survival data
Fierce Pharma
Sat, 05/30/15 - 05:28 pm
Pfizer
Ibrance
ASCO
breast cancer
J&J multiple myeloma drug offers hope after others stop working -study
Yahoo/Reuters
Sat, 05/30/15 - 11:55 am
JNJ
Multiple Myeloma
ASCO
daratumumab
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Wed, 05/27/15 - 11:26 am
Novartis
R&D
cancer
Tafinlar
Mekinist
GSK
ASCO
ASCO preview: What's coming for lung cancer
Medical Marketing and Media
Tue, 05/26/15 - 04:16 pm
ASCO
lung cancer
Bristol-Myers Squibb
Merck
Roche
Keytruda
Opdivo
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug
Forbes
Sun, 05/17/15 - 01:56 pm
ASCO
cystic fibrosis
neratinib
Puma Biotechnology
Bluebird Bio
SAGE Therapeutics
Orkambi
Vertex Pharmaceuticals
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
ASCO
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Genentech
MPDL3280A
MEDI4736
AstraZeneca
A preview of the new lung cancer data Roche will debut at ASCO
BioPharma Dive
Fri, 05/15/15 - 09:34 am
non-small cell lung cancer
ASCO
Roche
Genentech
MPDL3280A
PDL-1 inhibitors
Biotech: Asco Giveth, Asco Taketh Away
Barron's
Fri, 05/15/15 - 09:28 am
ASCO
biotech
Amgen
Gilead Sciences
Puma Biotechnology
Incyte
Celgene
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda

Pages